HONG KONG – Shanghai-based Fosun Kite Biotechnology Co. Ltd. was granted approval from China's National Medical Products Administration (NMPA) to advance its gene therapy candidate, FKC-876, to clinical trials.
HONG KONG – Shanghai-based biopharmaceutical firm Harbour Biomed Therapeutics Ltd. completed a series B financing of $85 million, "slightly above" its target, with the round led by Singapore's wealth fund GIC Private Ltd. Harbour anticipates more fundraising in 2019.
HONG KONG – Shanghai-based biopharmaceutical firm Harbour Biomed Therapeutics Ltd. completed a series B financing of $85 million, "slightly above" its target, with the round led by Singapore's wealth fund GIC Private Ltd. Harbour anticipates more fundraising in 2019.
HONG KONG – China purged about 40 provincial and local officials, including top staff of China's drug watchdog, after a meeting of the Politburo Standing Committee, led by President Xi Jinping, who pledged to punish rabies vaccine maker Changchun Changsheng Bio-technology Co., of Jilin Province, for stirring up fears for public health.
